Safety and feasibility of Y90 radioembolization for cirrhosis-induced splenomegaly and thrombocytopenia: results from an investigational device exemption study

Key Points

• Y90 radioembolization showed a favorable safety profile for patients with cirrhosis and thrombocytopenia.
• The study included a cohort of patients experiencing splenomegaly, showing promising outcomes after intervention.
• Assessment utilized an investigational device exemption approach to evaluate treatment effectiveness and safety.
• Findings suggest that Y90 radioembolization could be a viable option in treating symptoms related to cirrhosis.